SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001121781-14-000260
Filing Date
2014-08-19
Accepted
2014-08-19 15:12:06
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 MED-CANNABIS PHARMA, INC. mcp10q63014.htm 10-Q 372064
2 CHIEF EXECUTIVE OFFICER CERTIFICATION ex31one.htm EX-31.1 6997
3 CHIEF FINANCIAL OFFICER CERTIFICATION ex31two.htm EX-31.2 6964
4 CERTIFICATION ex32one.htm EX-32.1 3340
  Complete submission text file 0001121781-14-000260.txt   1618133

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE mcpi-20140630.xml EX-101.INS 178240
6 XBRL SCHEMA FILE mcpi-20140630.xsd EX-101.SCH 10754
7 XBRL DEFINITION FILE mcpi-20140630_def.xml EX-101.DEF 17348
8 XBRL LABEL FILE mcpi-20140630_lab.xml EX-101.LAB 87500
9 XBRL PRESENTATION FILE mcpi-20140630_pre.xml EX-101.PRE 70154
Mailing Address 2544 TARPLEY ROAD SUITE 12 CARROLLTON TX 75006
Business Address 2544 TARPLEY ROAD SUITE 12 CARROLLTON TX 75006 214-666-8364
Med-Cannabis Pharma, Inc. (Filer) CIK: 0001516559 (see all company filings)

IRS No.: 450704149 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54770 | Film No.: 141051853
SIC: 5190 Wholesale-Miscellaneous Nondurable Goods